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Background & Aims: Microsatellite instability (replica­
tion error [RER]-positive phenotype) is a frequent ge­
netic alteration in gastric carcinomas. The clinical rela­
tionship between RER-positive and RER-negative 
gastric tumors Is poorly characterized. The aim of this 
study was to investigate the relationship between the 
number of altered microsatellite loci and the clinico­
pathologic features of gastric carcinoma. Methods: 
Five or 6 microsatellite loci were analyzed in 61 gastric 
carcinomas using polymerase chain reaction. Results: 
Twenty-one carcinomas (34.4%) had microsateilite in­
stability: 7 at 1 locus, 2 at 2 loci, and 12 at multiple 
loci. The comparison between the three groups (with 
none, 1 or 2, and more than 2 RER-positive loci) 
showed that RER-negative carcinomas and carcinomas 
with 1 or 2 RER-positive loci share features that differ 
from those of carcinomas with multiple RER-positive 
loci. The latter were all of the intestinal or atypical 
subtype and had lower DNA content, more prominent 
lymphoid infiltration, and less prevalent nodal metasta- 
ses than carcinomas in the other two groups. The pa­
tients with carcinomas showing multiple RER-positive 
loci had a better prognosis. Conclusions: The finding 
of microsateilite instability in a single or few loci does 
not qualify a case as a mutator phenotype from a clini­
cal standpoint. Gastric tumors with multiple RER-posi- 
tive loci have a particular clinicopathologic profile lead­
ing to a better outcome.
Recently, subtle genetic alterations resulting in expansions or contractions of simple repeated se­
quences, the so-called microsateilite instability (MI), 
have been described in several human cancers,1"5 An 
association between the presence of MI and certain clini­
copathologic characteristics was observed for sporadic co­
lorectal carcinomas.1”3,6,7 Lot he et al.6 found that these 
differences relied on the number of altered microsateilite 
loci: carcinomas with multiple replication error (RER)- 
positive loci were significantly associated with poor 
differentiation, diploidy, right-sided location, and pro­
longed survival, whereas carcinomas with a single RER-
positive locus were similar to RER-negative carcinomas.6 
MI at either one or multiple loci was also observed in 
other cancers, but no clinical or pathological differences 
were found between these two groups of tumors.8,9
MI has been described as a frequent genetic alteration 
in gastric carcinomas,4,5,10"13 In a previous study,14 we 
investigated the frequency of RER-positive phenotype in 
a series of 34 sporadic gastric carcinomas by analyzing 4 —
12 loci per case. W e confirmed the frequent occurrence of 
the RER-positive phenotype in gastric carcinomas 
(32.4%) and observed that RER-positive gastric tumors 
tended to occur as intestinal or atypical carcinomas in 
the antrum of elderly patients, to have abundant T-cell 
infiltration, and to have a relatively good prognosis.14
1 A
In the aforementioned study, a presence of MI at a 
single locus was used as a criterion for classifying a case 
as RER-positive. Interestingly, only 1 o f the 34 carcino­
mas had MI in I locus.14 The remaining were either 
RER-negative (n =  23) or had MI at > 3  loci (n =  10), 
which suggested that there was a discontinuous distribu­
tion of the number of affected loci in gastric carcinomas, 
leading to the constitution of two groups: cases with no 
or very few affected loci and those with multiple affected 
loci. Also, we observed that the carcinoma with MI at 1 
locus shared the clinicopathologic features of the RER- 
negative carcinomas, thus differing from the other RER- 
positive cases.
In the present study, we extended the previous study 
of gastric carcinomas by analyzing a similar number of 
loci in all samples to better define the clinicopathologic 
profile(s) of RER-positive tumors and, in particular, to 
find whether there is a relationship between the number 
of altered microsateilite loci and the clinicopathologic 
features of gastric carcinoma.
Abbreviations used in this paper: cCTP, deoxycytidine triphos­
phate; Ml, microsateilite Instability; PCR, polymerase chain reaction; 
RER, replication error; WHO, World Health Organization.
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Materials and Methods
Patients, Tissue Samples, and DNA 
Extraction
We analyzed 61 gastric carcinomas and paired samples 
from nonneoplastic mucosa of white patients who underwent 
surgery at the Hospital S. Joao, Oporto, Portugal. Thirty-four 
of the 61 cases have been reported previously.14 None of the 
patients included in the present series had a family history 
suggestive of hereditary nonpolyposis colorectal cancer. H&E- 
stained sections were used to categorize tumors according to 
the classifications of the World Health Organization (WHO),15 
Lauren,16 and Ming.17 Penetration of the gastric wall and the 
presence and localization of lymph node metastases were re­
corded for all patients using standard criteria for pathological 
staging. Orcein-stained sections were used for the detection of 
vascular invasion. Lymphoid infiltration was subjectively 
scored as absent/minimal or moderate/abundant. Immunohis- 
tochemistry was used to classify the lymphocytic infiltration 
of the tumors according to the predominance of T or B lympho­
cytes using UCHL1 and L26 antibodies (Dako, Glostrup, Den­
mark), respectively. Ploidy was determined by flow cytometry 
in frozen samples as previously described.18
From each patient, tissue fragments from primary tumors 
and nonneoplastic mucosa were immediately frozen in liquid 
nitrogen and stored at — 70°C until use. The percentage of 
nonmalignant “contaminating” cells in the tumor samples was 
estimated by scoring adjacent histological cryostat sections, 
Microdissection of the specimens was performed whenever nec­
essary. Only samples with more than 50% of tumor cells were 
included in the study. High-molecular-weight DNA was iso­
lated using standard methods.ly
Microsateilite Marker Analysis
Six loci containing dinucleotide repeat sequences were
studied: D1S158, D2S104, D5S82, D5S346, D6S252, and
r
ARG1. Primers specific for each locus were used to amplify 
the repeat and short flanking sequences in template DNA 
using polymerase chain reaction (PCR). PCR was performed 
ppin a 25-|lL volume of a mixture containing 10 mmol/L Tris- 
HC1 (pH 8.0), 50 mmol/L KC1,1.5 mmol/L MgCl2, 100 |Llmol/
L of each deoxynucleotide triphosphate except deoxycytidine 
triphosphate (dCTP), 10 Jimol/L dCTP, 1 JLiCi [a-32P]dCTP,
0.4 (Imol/L of each primer, 0.75 U Taq DNA polymerase, and 
3 0 -5 0  ng genomic DNA. Thirty cycles of 94°C for 1 minute, 
55°C for 1 minute, and 72°C for 1.75 minutes were performed 
with an initial denaturation step of 94°C for 5 minutes and a 
final extension step of 72°C for 10 minutes using a Perkin— 
Elmer 9600 GeneAmp PCR System (Perkin-Elmer, Norwalk, 
CT). PCR reaction products were diluted 1:1 with a loading 
buffer (98% formamide, 0,1% xylene cyanol, 0.1% bromophe- 
nol blue, and 10 mmol/L ethylenediaminetetraacetic acid [pH 
8.0]) and then denatured for 5 minutes at 95°C. Subsequently,
2 |XL of this solution was electrophoresed in 6% polyacrylamide 
gels containing 6.9 mol/L u re a  and 32.5% formamide for 2—
3 hours at 60 W. After electrophoresis, gels were fixed in 10%
acetic acid, washed, dried, and exposed to x-ray film for 12 — 
24 hours. All scoring was performed independently by two 
observers. Five or 6 loci were analyzed per case. Of the 61 
tumors, 16 tumors were analyzed at 5 loci and 45 tumors were 
analyzed at 6 loci. A case was considered positive when at least
1 locus had a different mobility band. All RER-positive loci 
were confirmed by a new PCR and electrophoretic run.
Statistical Analysis
Statistical analysis was performed using the %2 test with 
Yates’ correction, Fisher’s Exact Test, or Student's t test using 
Statview 4.01 software. Follow-up data were obtained in all 
but 1 patient. Survival curves were calculated according to 
Berkson’s actuarial method and compared using the general­
ized Wilcoxon (Breslow) test using BMDP (PC-92) software 
(BMDP Statistical Software, Cork, Ireland). A P value of 
<0.05 was considered statistically significant, and a P value 
of <0.1 was considered suggestively significant.
Results
Twenty-one of 61 carcinomas (34.4% ) had MI 
(Figure 1). Of the 21 RER-positive carcinomas, 7, 2, 2, 
5 ,4 , and 1 had MI at 1, 2, 3 ,4 , 5, and 6 loci, respectively. 
O f the 7 tumors that showed only 1 affected microsatei­
lite, 6 were analyzed at 6 loci and 1 was analyzed at 5 
loci. The 2 tumors that showed 2 affected microsatellites 
were analyzed at 6 loci. Of the 12 tumors with MI at 
^=3 or more loci (multiple loci), 2 were analyzed at 5 
loci and 10 were analyzed at 6 loci. Both microsateilite 
expansions and contractions were identified indepen­
dently of the number of altered loci.
After having verified that the 2 carcinomas with RER- 
positive at 2 loci had clinicopathologic features almost 
identical to those of carcinomas with 1 RER-positive 
locus, we divided the RER-positive carcinomas in two 
groups: a group of 9 carcinomas with 1 or 2 RER-positive 
loci and a group of 12 carcinomas with m ultiple RER- 
positive loci (Table 1). Clinical and pathological data of 
the gastric carcinomas are shown in Table 1. Because we 
perceived that most clinicopathologic features of carcino­
mas with 1 or 2 RER-positive loci were similar to those 
of RER-negative carcinomas (Table 1) and different from 
those of carcinomas with multiple RER-positive loci, we 
joined the former two groups of carcinomas and com ­
pared them with the latter (Table 2).
According to Laurens classification, none o f the carci­
nomas with multiple RER-positive loci were of the dif­
fuse type, in contrast to 35% carcinomas with none or
1 or 2 RER-positive loci (P =  0.06). These differences 
were also noted for histological typing according to 
W H O  classification because no signet ring cell or mu­
cinous gastric carcinoma had MI at more than 2 loci 
(P <  0.1). At variance with carcinomas with none or 1
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Table 1. Relation Between Ml (RER-Positlve Phenotype) and Clinicopathologic Characteristics of the Gastric Carcinoma
Cases
Number of cases with (+) or without (-) RER
Clinicopathologic
characteristics
RER-negative
(n = 40)
RER-positive at 1 or 2 loci
(n = 9)
RER-positive at >3 loci 
(n -  12)
Total 
(n « 61) P value3
Age (mean ± SD) 59.2 ± 12.9 62.7 ± 12.5 63.8 ± 10.6 61.5 ± 12,1 NS
Male/female , 1.7/1 3.5/1 1/1 0.7/1 NS
Location
Antrum 20 6
«
8 34
Body 14 2 3 19
Cardia 6 1 0 7 NS
Gross type
Vegetative 12 0 6 18
Ulcerated 13 5 4 22
Infiltrating 14 4 2 20 NS
Size ± SD (cm) 7.7 ± 4.9 8.5 ± 8.9 10.3 ± 4.6 8.1 ± 5.3 NS
Classification of Laurén16
Intestinal 14 4 7 25
Diffuse 14 3 0 17
Atypical 12 2 5 19 NS
Classification of WHOe
Well-differentiated 14 4 8 26
Poorly differentiated 12 2 4 18
Signet-ring cell 12 3 0 15
Mucinous 2 0 0 2 NS
Classification of Ming17
Expanding 13 4 8 25
Infiltrative 27 5 4 36 NS
Lymphoid infiltrate
Minimal/absent 31 7 4 42
Moderate/abundant 9 2i 8 19 0.012
Desmoplastic response
Minimal/absent 25 5 12 42
Moderate/abundant 15 4 0 19 0.031
Vascular invasion
Absent 16 5 6 27
Present 24 4 6 34 NS
Wall invasion
Within the gastric wall 32 7 9 48
Invading the serosa» 8 2 3 13 NS
Lymph node métastasés
Absent 7 4 6 17
Present 33 5 6 44 0.043
DNA index ± SDd 1.49 ± 0.48 1.42 ± 0.36 1.12 ± 0.20 1.42 ± 0,48 0.012
S-phase fraction ± SDd 20.3 ± 8.2 23.4 ± 13.4 17.4 ± 3.4 20.0 ± 8.6 NS
°P value was obtained using x2 test with Yates’ correction and Student’s t test (NS = P s= 0.01). 
*ln 1 patient, location was not determined.
^Simplified version of WHO classification.
rfin 10 cases, DNA index and S-phase fraction were not determined.
or 2 RER-positive loci, carcinomas with multiple RER- 
positive loci showed predominantly expanding growth 
pattern (P == 0.06) and always had minimal or absent 
desmoplastic response (P <  0.05) (Table 2).
Statistically significant differences were also observed re­
garding lymphoid infiltrate (P <  0.01) and D N A  content 
(P <  0.005) (Table 2). Sixty-seven percent of gastric carci­
nomas with more than 2 RER-positive loci had moderate 
or abundant lymphoid infiltrate in contrast to only 22% of 
carcinomas with none or few RER-positive loci. Lymphoid
infiltration was mainly composed of T cells, as assessed by 
immunohistochemistry (data not shown). All carcinomas 
with MI at multiple loci were diploid or near diploid (aver­
age DNA index, 1.04 ±  0.07), and most carcinomas with­
out MI or with 1 or 2 affected loci had aneuploid D N A  
content (average DNA index, 1.48 ±  0.46).
The percentage of cases with lymph node métastasés
was lower (P =  0.08) in the group o f carcinomas w ith
/
multiple RER-positive loci (50%) than in the other 
group of carcinomas (78%).
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TaMe 2. Significant clinicopathologic Differences Between Gastric Carcinomas With Ml at Multiple Loci and carcinomas With
Ml at None, One, or Two Loci
Clinicopathologic
characteristics
Classification of Laurén16 
Intestinal 
Diffuse 
Atypical 
Classification of WHOb 
Well'd ifferentiated 
Poorly differentiated 
Signet-ring cell 
Mucinous 
Classification of Ming17
Expanding
Infiltrative 
Lymphoid infiltrate 
Minimal/absent 
Moderate/abundant 
Desmoplastic response
Minimal/absent
Moderate/abundant 
Lymph node métastasés 
Absent 
Present 
DNA index ± SDe
No. of cases with (+) or without (-)  RER
RER-positive at s 2  loci (n = 49) RER-positive at &3 loci (n ~ 12)
18
17
14
IS
14
15 
2
17
32
38
11
30
19
11
38
1.48 ± 0,46
7
0
5
8
4
0
0
8
4
4
8
12
0
6
6
1.04 ± 0.07
HVPP
upvalue was obtained using x 2 test with Yates' correction and Fisher’s Exact Test. 
^Simplified version of WHO classification. 
cJn 10 cases, DNA index was not determined.
Total (n -  61)
25
17
19
26
18
15
2
/I ill
V J
36
42
19
42
17
44
1.42 0.48
F value"
0.055
0,099
0.091
0. i f  Y*f +¿1
0.024
0.056
0.003
Univariate analysis showed that patients with carcino- small she of the sample and die short follow-up rime in
mas with MI at m ultiple loci had significantly better most* patients
survival (P <  0.05) than patients with carcinomas with 
no RER or with 1 or 2 RER-positive loci (Figure 2). 
Multivariate analysis was not performed because o f the
Figure 2. Cause-specific survival (death from gastric cancer; Berk* 
son s actuarial method) for 60 patients .with relation to Ml. A, carcino* 
mas with no Ml (n = 39); B, carcinomas with 1 or 2 RER* loci 
(n = 9); C, carcinomas with multiple RER-positive loci (n = 12). The 
comparison of C vs. A and B yields a statistically significant difference 
(P = 0.026) using the generalized Wilcoxon (Breslow) test.
>w-up, 3 years).
Discussion
In a previous study» we detected MI in of
34 cases of gastric carcinomas1'1 and found that these 
RER-positive carcinomas were associated with some d in -  
icopathologic features, as previously reported in studies 
on colorectal carcinomas,1 u ’1?
In the present study, we extended die previous study 
to a total of 61 patients and detected 21 gastric tan ino 
mas with Ml (34,4%). Of these 21 RER-positive eareino
mas, 9 had MI instability at 1 {n =  7) or 2 loti (u «  
2) and 12 had MI at multiple loci. Alter comparing the 
clinicopathologic features of the three ¿»roups o f  cart ¡no­
mas (RER-negative, RER-positive at lew loci, and RHR- 
positive at multiple loci), we found that carcinomas with  
none or 1 or 2 RER-positive loci share .several features 
that are different from those of carcinomas with multiple  
RER-positive loci. These observations prompted us to 
compare carcinomas with multiple RER-positive loci 
with the remaining carcinomas, leading to the finding 
of an association between the presence o f  multiple RKR 
positive loci and intestinal/atypical histological diiieren 
tiation, expanding growth pattern, absent or minimal
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desmoplastic response, abundant lymphoid infiltration, and clinicopathologically indistinguishable from RER- 
low DNA content, relatively low frequency of lymph negative carcinomas, it seems likely that the generation
node metastization, and better prognosis.
At variance with our previous study14 in which we 
classified every carcinoma having MI as a mutator pheno­
type regardless of the number of affected loci, our present 
results indicate that MI is only associated with a particu­
lar set of clinicopathologic features when it occurs at 
multiple loci, as was previously shown by Lothe et al.6 
in a study of colorectal carcinomas. Our results, similar 
to those of Thibodeau et al.2 and Lothe et al.,6 therefore
of MI in these tumors is just part of the bulk of secondary 
genetic changes related to tumor progression.
All carcinomas with multiple RER-positive were clas­
sified as intestinal or atypical gastric carcinomas in keep­
ing with previous reports.10^ 12 The low frequency of MI 
in diffuse carcinomas does not seem to be an underrepre­
sentation caused by stromal contamination because, in 
the present study, we only included study samples with 
more than 50% of tumor cells. We also observed associa-
show that one cannot rely on the finding of a single or tions between the presence of the RER-positive pheno-
a few RER-positive loci to consider a gastrointestinal type and the occurrence of minimal or absent desmoplas-
carcinoma as being a mutator phenotype from a clinico- tic response (P <  0.05) and expanding growth pattern
pathologic standpoint. It is likely that the drawing line (P =  0,09). These associations are not unexpected because
distinguishing “positive” from “negative” cases will de­
pend on the number of loci analyzed and on the number 
and characteristics of the markers used in each study.
the aforementioned features are also strongly associated 
(P — 0.001, %2 test) with the intestinal and atypical 
types of gastric carcinoma. We verified that no cardiac
At least three hypotheses can explain the clinicopatho- carcinoma had MI at multiple loci, thus confirming that 
logic disparity between carcinomas with few RER-posi- mutator phenotype cancers have particular organ loca­
tive loci and carcinomas with multiple RER-positive loci. tions, although this had no statistical significance.1,6,7111,14
First, the occurrence of MI at few loci may represent a We observed a significant association between RER-
random event or an abnormality of one of the DNA positive phenotype and low (diploid or near diploid)
polymerases, whereas the occurrence of MI at multiple DNA content, as previously reported for coLorectal carci-
loci may indicate abnormalities of DNA mismatch repair nomas.6 These findings point to the possibility that the
genes. Second, mutations in different mismatch repair RER-positive mutator phenotype and the gross genetic
alterations associated with aneuploidy may be each one 
part of two alternative pathways in tumor development, 
as previously suggested by Chong et al.10 and Shibata et
genes or in different domains of those genes can lead to 
a variable degree of hypermutability.20 Carcinomas with 
a few RER-positive loci may carry a distinct mismatch 
repair deficiency compared with carcinomas with multi- al. On the other hand, the frequent acquisition of a 
pie RER-positive loci, therefore conferring to the former mismatch repair deficiency, manifested as MI in intesti- 
characteristics similar to those of RER-negative carcino- nal and atypical gastric carcinomas and not in diffuse 
mas. In agreement with this possibility, Bhattacharyya 
et al.21 reported colorectal carcinoma ceil lines showing 
quite different rates of MI. Third, inactivating mutations 
in mismatch repair genes resulting in mismatch repair
carcinomas, supports the existence of two carcinogenic 
pathways for gastric carcinoma, one leading to the intes­
tinal type and the other to the diffuse type.23,24
Our finding of an association between the presence of
deficiency may occur at different steps during tumor multiple RER-positive loci and the lower prevalence of 
progression. Carcinomas with 1 or 2 RER-positive loci lymph node metastization is in accordance with the nega-
may have acquired the RER-positive phenotype in an 
advanced phase of tumor progression, therefore not giv-
tive correlation found between MI and metastization, 
previously reported in gastric carcinomas11 and colorectal
ing enough time to yield distinctive clinicopathologic carcinomas.1 The low prevalence of lymph node metasti- 
features. In contrast, carcinomas with MI at multiple loci zation most likely accounts for the good outcome of the
would have acquired a mismatch repair deficiency in 
earlier steps of tumor progression, thus leading to the 
accumulation of multiple mutations throughout the ge­
nome, including microsatellite and gene sequences.
patients with carcinomas with multiple RER-positive 
loci, as previously reported for colorectal cancer. 1
The statistically significant association between the 
presence of MI and moderate/abundant lymphoid in.fi 1-
It is difficult or even impossible to evaluate the plausi- tration confirms our previous results14 and, together with 
bility of the aforementioned hypotheses without knowing the presence of Crohn’s-like lymphoid reaction in colo- 
what is going on at the different mismatch repair genes rectal RER-positive carcinomas,7 supports the assump-
that may be involved in generating MI in gastric carcino tion that unrepaired errors in certain genes can lead to
mas. However, if one takes in consideration that carcino- the appearance of new surface molecules and thereby 
mas with "few” RER-positive loci are mostly aneuploid trigger an immune response. This mechanism may ac-
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count for the better prognosis of patients with carcinomas 
with multiple RER-positive loci if one assumes that the 
immune response may limit the invasive and/or meta­
static ability of the tumors.
The mutator phenotype may also contribute for the 
better clinical outcome of patients with multiple RER- 
positive loci through the acquisition of a mutation bur­
den, which can yield deleterious mutations in vital 
genes.22,25 A mutational load may negatively condition 
the selective advantage conferred by favorable mutations 
in cancer-related genes, therefore leading to an indolent 
tumoral progression and low metastatic potential. This 
scenario is in agreement with the lower proliferative in­
dex of carcinomas and older age of patients with multiple 
RER-positive loci.
In summary, the finding of MI in a single or few 
loci does not qualify a gastric cancer case as a mutator 
phenotype from a clinical standpoint, whereas gastric 
carcinomas with multiple RER-positive loci have a par­
ticular clinicopathologic profile leading to a better out­
come.
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